Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) EBIT (2017 - 2025)

Inspire Medical Systems' EBIT history spans 9 years, with the latest figure at $46.1 million for Q4 2025.

  • For Q4 2025, EBIT rose 44.62% year-over-year to $46.1 million; the TTM value through Dec 2025 reached $51.0 million, up 41.21%, while the annual FY2025 figure was $51.0 million, 41.21% up from the prior year.
  • EBIT for Q4 2025 was $46.1 million at Inspire Medical Systems, up from $9.6 million in the prior quarter.
  • Across five years, EBIT topped out at $46.1 million in Q4 2025 and bottomed at -$19.5 million in Q1 2023.
  • The 5-year median for EBIT is -$6.6 million (2021), against an average of -$2.0 million.
  • The largest annual shift saw EBIT surged 2875.22% in 2023 before it tumbled 165.03% in 2025.
  • A 5-year view of EBIT shows it stood at -$1.8 million in 2021, then soared by 81.6% to -$335000.0 in 2022, then soared by 2875.22% to $9.3 million in 2023, then skyrocketed by 242.95% to $31.9 million in 2024, then soared by 44.62% to $46.1 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's EBIT are $46.1 million (Q4 2025), $9.6 million (Q3 2025), and -$3.3 million (Q2 2025).